UNIGE document Scientific Article
previous document  unige:85069  next document
add to browser collection
Title

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation

Authors
Brigger, I.
Chaminade, P.
Marsaud, V.
Appel, M.
Besnard, M.
Renoir, M.
Couvreur, P.
Published in International Journal of Pharmaceutics. 2001, vol. 214, no. 1-2, p. 37-42
Abstract When dealing with solid tumors in vivo, pegylated long-circulating carrier systems show, after intravenous administration, an attractive extravasation profile with an enhanced localization in the tumoral interstitium. These systems could be of help for the delivery of cancer fighting drugs, such as Tamoxifen, a well known antiestrogen used in breast cancer therapy that possesses an extended biodistribution in vivo. This work aimed at encapsulating Tamoxifen in long-circulating poly(MePEGcyanoacrylate-co-hexadecylcyanoacrylate) 1:4 nanospheres. Tamoxifen-loaded poly(MePEGcyanoacrylate-co-hexadecylcyanoacrylate) nanospheres were successfully synthesized and characterized in terms of hydrophilicity/hydrophobicity by a model made up from near infrared spectra using principal component analysis. Zeta potential, drug loading, encapsulation efficiency, as well as biological effect, in vitro release and nanospheres integrity were also investigated. Even though near infrared spectroscopy could not detect Tamoxifen, it revealed that Pluronic F68 was associated with the pegylated nanospheres. HPLC measurements demonstrated that Tamoxifen was encapsulated in the pegylated nanospheres following a partition equilibrium between the polymeric and the aqueous phases. The Tamoxifen encapsulated in the nanospheres still showed a transcription inhibitory activity in ex vivo experiments. However, zeta potential and in vitro release suggested that Tamoxifen was essentially localized at the nanoparticles surface, resulting in an important and immediate drug release.
Keywords NanospheresNear infrared hydrophilic/hydrophobic modelPoly(MePEGcyanoacrylate-co-hexadecylcyanoacrylate)TamoxifenTranscription inhibitory activity
Identifiers
PMID: 11282234
Full text
Article (Published version) (162 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Citation
(ISO format)
BRIGGER, I. et al. Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. In: International Journal of Pharmaceutics, 2001, vol. 214, n° 1-2, p. 37-42. https://archive-ouverte.unige.ch/unige:85069

71 hits

1 download

Update

Deposited on : 2016-07-06

Export document
Format :
Citation style :